Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway
As a natural active substance, dihydromyricetin (DHM) has been proven to have good hepatoprotective activity. However, the therapeutic effect of DHM on liver fibrosis, which has become a liver disease threatening the health of people around the world, has not been studied to date. The purpose of thi...
Guardado en:
Autores principales: | Yingchun Zhao, Xinglong Liu, Chuanbo Ding, Yan Gu, Wencong Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a2a7462f8fa45a19b213c49e478ef9b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proinflammatory Responses of 1-Nitropyrene against RAW264.7 Macrophages through Akt Phosphorylation and NF-κB Pathways
por: Ping-Kun Tsai, et al.
Publicado: (2021) -
HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas
por: Yunfei Wang, et al.
Publicado: (2021) -
Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway
por: Ji Hu, et al.
Publicado: (2021) -
miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway
por: Zhou Weidong, et al.
Publicado: (2021) -
ω-3 DPA Protected Neurons from Neuroinflammation by Balancing Microglia M1/M2 Polarizations through Inhibiting NF-κB/MAPK p38 Signaling and Activating Neuron-BDNF-PI3K/AKT Pathways
por: Baiping Liu, et al.
Publicado: (2021)